Fresh surgical specimens yield breast stem/progenitor cells and reveal their oncogenic abnormalities

Annals of Surgical Oncology

Volumn 19, Issue 2, 2012, Pages 527-535

  Pommier, Suellen J ^a   Hernandez, Ariel ^a   Han, Esther ^a   Massimino, Kristen ^a   Muller, Patrick ^a   Diggs, Brian ^a   Chamberlain, Erin ^b   Murphy, Jennifer ^a   Hansen, Juliana ^a   Naik, Arpana ^a   Vetto, John ^a   Pommier, Rodney F ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; CD24 ANTIGEN; PROTEIN KINASE B;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STEM CELL; CANCER TISSUE; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; OPERATING ROOM;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; MUTATION; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84856665628     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1892-z     Document Type: Article

References (37)

1. EH Huang DG Heidt CW Li, et al. 2007 Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance Surgery. 141 415 419 17383517 10.1016/j.surg.2006.12.015
2. MF Clarke JE Dick PB Dirks, et al. 2006 Cancer stem cells-perspective on current status and future directions: AACR Workshop of Cancer Stem Cells Cancer Res. 66 9339 9344 16990346 10.1158/0008-5472.CAN-06-3126 1:CAS:528: DC%2BD28XhtVamsr3I
3. MS Wicha S Liu G Dontu 2006 Cancer stem cells: an old idea-a paradigm shift Cancer Res. 66 1883 1890 16488983 10.1158/0008-5472.CAN-05-3153 1:CAS:528:DC%2BD28XhsFamtbw%3D
4. G Dontu M Al-Hajj WM Abdallah, et al. 2003 Stem cells in normal breast development and breast cancer Cell Prolif 36 Suppl 1 59 72 14521516 10.1046/j.1365-2184.36.s.1.6.x 1:CAS:528:DC%2BD3sXpsFChtr0%3D
5. R Dulbecco M Henahan B Armstrong 1982 Cell types and morphogenesis in the mammary gland Proc Natl Acad Sci USA. 79 7346 7350 6961412 10.1073/pnas.79.23. 7346 1:STN:280:DyaL3s7hslKktw%3D%3D
6. N Shafee CR Smith S Wei, et al. 2008 Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors Cancer Res. 68 3243 3250 18451150 10.1158/0008-5472.CAN-07-5480 1:CAS:528:DC%2BD1cXltlSmu7g%3D
7. TM Phillips WH McBride F Pajonk 2006 The response of CD29(-/low)/CD44+ breast cancer-initiating cells to radiation J Natl Cancer Inst. 98 1777 1785 17179479 10.1093/jnci/djj495
8. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet. 365 1687 1717 10.1016/S0140-6736(05)66544-0
9. J Stingl P Eirew I Ricketson, et al. 2006 Purification and unique properties of mammary epithelial stem cells Nature. 1038 1 5
10. M Shackleton F Vaillant KJ Simpson, et al. 2006 Generation of a functional mammary gland from a single stem cell Nature. 439 84 88 16397499 10.1038/nature04372 1:CAS:528:DC%2BD28Xht1aqsw%3D%3D
11. J Stingl 2009 Detection and analysis of mammary gland stem cells J Pathol 217 229 241 19009588 10.1002/path.2457 1:STN:280:DC%2BD1M%2Fgtl2hsQ%3D%3D
12. R Villadsen AJ Fridriksdottir L Ronnov-Jessen, et al. 2007 Evidence for a stem cell hierarchy in the adult human breast J Cell Biol. 177 87 101 17420292 10.1083/jcb.200611114 1:CAS:528:DC%2BD2sXktlKltr0%3D
13. T Gudjonsson R Villadsen HL Nielsen, et al. 2002 Isolation, immortalization and characterization of human breast epithelial cell lines with stem cell properties Genes Dev. 16 693 706 11914275 10.1101/gad.952602 1:CAS:528:DC%2BD38XisVaju7k%3D
14. M Al-Hajj MS Wicha A Benito-Hernandez, et al. 2003 Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci USA. 100 3983 3988 12629218 10.1073/pnas.0530291100 1:CAS:528:DC%2BD3sXivFSqtbs%3D
15. MJ Grimshaw L Cooper K Papazisis, et al. 2008 Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells Breast Cancer Res. 10 R52 18541018 10.1186/bcr2106
16. Y Samuels Z Wang A Bardelli, et al. 2004 High frequency of mutations of the PIK3CA gene in human cancers Science. 302 554 10.1126/science.1096502
17. KE Bachman P Argani Y Samuels, et al. 2004 The PIK3CA gene is mutated with high frequency in human breast cancers Cancer Biol Ther. 3 772 775 15254419 10.4161/cbt.3.8.994 1:CAS:528:DC%2BD2MXhslKrtbw%3D
18. B Karakas KE Bachman BH Park 2006 Mutation of the PIK3CA oncogene in human cancers Br J Cancer. 94 455 459 16449998 10.1038/sj.bjc.6602970 1:CAS:528:DC%2BD28Xhs1ers70%3D
19. A Michelucci C Di Cristofano A Lami, et al. 2009 PIK3CA in breast carcinoma: a mutational analysis of sporadic and hereditary cases Diagn Mol Pathol. 18 200 205 19861897 10.1097/PDM.0b013e31818e5fa4 1:CAS:528: DC%2BD1MXhsV2isrjL
20. J Dunlap C Le A Shukla, et al. 2010 Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma Breast Cancer Res Treat. 120 409 418 19418217 10.1007/s10549-009-0406-1 1:CAS:528:DC%2BC3cXjtlahurw%3D
21. SJ Isakoff JA Engelman HY Irie, et al. 2005 Breast Cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells Cancer Res. 65 10992 11000 16322248 10.1158/0008-5472.CAN-05-2612 1:CAS:528:DC%2BD2MXht1Kjsr3M
22. I Vivanco CL Sawyers 2002 The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer. 2 489 501 12094235 10.1038/nrc839 1:CAS:528:DC%2BD38XkvFKltLs%3D
23. S Kang AG Bader PK Vogt 2004 Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic Proc Natl Acad Sci USA. 103 802 807
24. Y Samuels LA Diaz Jr O Schmidt-Kittler, et al. 2005 Mutant PIK3CA promotes cell growth and invasion of human cancer cells Cancer Cell. 7 561 573 15950905 10.1016/j.ccr.2005.05.014 1:CAS:528:DC%2BD2MXlslCgsrY%3D
25. JD Carpen AL Faber C Horn, et al. 2007 A transforming mutation in the pleckstrin homology domain of AKT1 in cancer Nature. 448 439 444 10.1038/nature05933
26. FE Bleeker L Felicioni F Buttitta, et al. 2008 AKT1 (E17K) in human solid tumours Oncogene. 27 5648 5650 18504432 10.1038/onc.2008.170 1:CAS:528:DC%2BD1cXhtFant7zL
27. MS Kim EG Jeong NJ Yoo, et al. 2008 Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias Br J Cancer. 98 1533 1535 18392055 10.1038/sj.bjc.6604212 1:CAS:528:DC%2BD1cXltl2itrc%3D
28. Y Samuels K Ericson 2006 Oncogenic PI3 K and its role in cancer Curr Opin Oncol. 18 77 82 16357568 10.1097/01.cco.0000198021.99347.b9 1:CAS:528:DC%2BD2MXhtlahu73P
29. LH Saal K Holm M Maurer, et al. 2005 2005 PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma Cancer Res. 65 2554 2559 15805248 10.1158/0008-5472-CAN-04-3913 1:CAS:528:DC%2BD2MXjtVeqsrc%3D
30. K Stemke-Hale AM Gonzalez-Angulo A Lluch, et al. 2008 An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer Cancer Res. 68 6084 6091 18676830 10.1158/0008-5472.CAN-07-6854 1:CAS:528:DC%2BD1cXpt1SqtLs%3D
31. G Dontu WM Abdalla JM Foley, et al. 2003 In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells Genes Dev. 17 1253 1270 12756227 10.1101/gad.1061803 1:CAS:528:DC%2BD3sXktVGmt7s%3D
32. KJ Livak TD Schmittingen 2001 Analysis of relative gene expression data using real-time quantitative PCR and 2-AACt method Methods. 25 402 408 11846609 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D
33. A Hollestelle F Elstrodt JHA Nagel, et al. 2007 Phosphatidylinositol-3-OH kinase of RAS pathway mutations in human breast cancer cell lines Mol Cancer Res. 5 195 201 17314276 10.1158/1541-7786.MCR-06-0263 1:CAS:528: DC%2BD2sXhvFWrtb8%3D
34. M Rivera RM Ricarte-Filho J Knauf, et al. 2010 Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns Mod Pathol. 23 1191 1200 20526288 10.1038/modpathol.2010.112 1:CAS:528:DC%2BC3cXhtV2hu73I
35. SJ Pommier GG Quan D Christante, et al. 2009 Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells Ann Surg Oncol. 17 613 623 19838757 10.1245/s10434-009-0730-z
36. LC Cantley 2002 The phosphoinositide 3-kinase pathway Science. 296 1655 1657 12040186 10.1126/science.296.5573.1655 1:CAS:528:DC%2BD38XktlChu7s%3D
37. R Katso K Okkenhaug K Ahmadi, et al. 2001 Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer Annu Rev Cell Dev Biol. 17 615 675 11687500 10.1146/annurev.cellbio.17.1. 615 1:CAS:528:DC%2BD3MXos1OmsbY%3D